Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

3.95
Delayed Data
As of 3:59pm ET
 +0.04 / +1.02%
Today’s Change
3.11
Today|||52-Week Range
9.37
-34.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
AssetsCash31.1M68.4M104.2M75.1M
 
 
 
 
 
Short Term Investment Cash-6.5M37.3M35.9M-29.2M
 
 
 
 
 
Cash & Short Term Investments133.3M118.6M205.5M188.6M
 
 
 
 
 
 
ReceivablesReceivables4.1M32.0M2.6M4.5M
 
 
 
 
 
 
InventoriesInventories--754.0K1.2M1.4M
 
 
 
 
 
Current AssetsOther Current Assets1.7M1.8M2.0M1.8M
 
 
 
 
 
Current Assets139.1M153.2M211.3M196.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.6M2.7M2.9M2.9M
 
 
 
 
 
Depreciation-2.0M-2.0M-2.1M-2.1M
 
 
 
 
 
Other Assets884.0K426.0K621.0K612.0K
 
 
 
 
 
Total Assets140.9M154.5M213.0M198.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable8.1M4.7M4.2M2.5M
 
 
 
 
 
Accrued Expenses10.3M9.8M12.6M13.3M
 
 
 
 
 
Other Current Liabilities13.7M13.3M20.8M21.5M
 
 
 
 
 
Other Liabilities24.6M21.7M29.7M25.9M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt81.9M82.9M83.9M84.9M
 
 
 
 
 
Deferred Taxes0.000.00-547.0K-547.0K
 
 
 
Other Liabilities401.0K378.0K354.0K305.0K
 
 
 
 
 
Total Liabilities140.3M137.6M190.6M185.7M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity547.0K16.9M22.3M12.3M
 
 
 
 
 
Total Shareholder Equity547.0K16.9M22.3M12.3M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding122.5M123.1M123.5M124.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.